首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Peroral administration of 5-bromo-2-deoxyuridine in drinking water is not a reliable method for labeling proliferating S-phase cells in rats
【24h】

Peroral administration of 5-bromo-2-deoxyuridine in drinking water is not a reliable method for labeling proliferating S-phase cells in rats

机译:饮用水中5-溴-2-脱氧尿苷的运动不是一种可靠的方法,用于在大鼠中标记增殖的S相细胞

获取原文
获取原文并翻译 | 示例
           

摘要

In rodents, peroral (p.o.) administration of 5-bromo-2'-deoxyuridine (BrdU) dissolved in drinking water is a widely used method for labeling newly formed cells over a prolonged time-period. Despite the broad applicability of this method, the pharmacokinetics of BrdU in rats or mice after p.o. administration remains unknown. Moreover, the p.o. route of administration may be limited by the relatively low amount of BrdU consumed over 24 h and the characteristic drinking pattern of rats, with water intake being observed predominantly during the dark phase. Therefore, we investigated the reliability of staining proliferating S-phase cells with BrdU after p.o. administration (1 mg/ml) to rats using both in vitro and in vivo conditions. Flow cytometric analysis of tumor cells co-cultivated with sera from experimental animals exposed to BrdU dissolved in drinking water or 25% orange juice revealed that the concentration of BrdU in the blood sera of rats throughout the day was below the detection limits of our assay. Ingested BrdU was only sufficient to label approximately 4.2. ±. 0.3% (water) or 4.2 ± 0.3% (25% juice) of all S-phase cells. Analysis of data from in vivo conditions indicates that only 7.6 ± 3.3% or 15.5 ± 2.3% of all S-phase cells in the dentate gyrus of the hippocampus was labeled in animals administered drinking water containing BrdU during the light and dark phases of the day. In addition, the intensity of BrdU-positive nuclei in animals receiving p.o. administration of BrdU was significantly lower than in control animals intraperitoneally injected with BrdU. Our data indicate that the conventional approach of p.o. administration of BrdU in the drinking water to rats provides strongly inaccurate information about the number of proliferating cells in target tissues. Therefore other administration routes, such as osmotic mini pumps, should be considered for labeling of proliferating cells over a prolonged time-period.
机译:在啮齿类动物中,口服溶解于饮用水中的5-溴-2'-脱氧尿苷(BrdU)是一种广泛使用的方法,用于在较长时间内标记新形成的细胞。尽管该方法具有广泛的适用性,但口服给药后BrdU在大鼠或小鼠体内的药代动力学仍然未知。此外,p.o.给药途径可能受限于24小时内消耗的BrdU量相对较低,以及大鼠特有的饮水模式,主要是在黑暗阶段观察到饮水。因此,我们在体外和体内条件下研究了大鼠在p.o.给药(1 mg/ml)后用BrdU染色增殖S期细胞的可靠性。对与暴露于溶解于饮用水或25%橙汁中的BrdU的实验动物的血清共同培养的肿瘤细胞进行流式细胞术分析,发现大鼠全天血清中BrdU的浓度低于我们的检测限。摄入的BrdU仅足以标记约4.2。±. 0.3%(水)或4.2±0.3%(25%果汁)的所有S期细胞。对活体条件下数据的分析表明,在一天中的明暗期,在饮用含有BrdU的水的动物中,海马齿状回所有S期细胞中只有7.6±3.3%或15.5±2.3%被标记。此外,在接受p.o.注射BrdU的动物中,BrdU阳性细胞核的强度显著低于腹腔注射BrdU的对照动物。我们的数据表明,在大鼠饮用水中p.o.给药BrdU的传统方法提供了有关靶组织中增殖细胞数量的非常不准确的信息。因此,其他给药途径,如渗透微型泵,应考虑在较长时间内标记增殖细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号